z
banner
squares
Leading Manufacturer of High Quality Intravenous Fluids in the Philippines
HOME ABOUT US PRODUCTS disclosures CONTACTS
disclosure

Main Office:

2nd Floor, PPL Bldg.,
UN Avenue corner
San Marcelino St.,
Manila, Philippines

Tel: (632) 524-0091 to 98
Fax: (632) 526-0977

Email: corporate@euromedlab.net
  disclosure    
     
 
EURO-MED Disclosures submitted to PSEC
Euro-Med 17A for the year ended Decmber 31 2006
Fire Incident at Euro-Med's Office
2007 Annual Stockholders Meeting and Election of Directors
Organizational Meeting of Board of Directors, 20 June 2007
Amended Disclosure: List of Elected Officers 2007-2008
Computation of Public Ownership as of 30 June 2007
Resignation and Appointment of Corporate Secretary
Board Lot as of 31 August 2007
Euro-Med's Manila Office Return to PPL Building
Board Lot as of 30 September 2007
Euro-Med Top 100 as 30 September 2007
Computation of Public Ownership as of 30 September 2007
Board Lot as of 31 October 2007
Euro-Med: SEC Form 17Q, 3rd Quarter
Board Lot as of 30 November 2007
Declaration of 10% Stock Dividends by the Board of Directors
Euro-Med Top 100 as of 30 December 2007
Amendment of Manual on Corporate Governance
Computation of Public Ownership as of 31 December 2007
Certification on Corporation's Compliance with its Manual on Corporate Governance for year 2007
Certification on the Attendance of Directors in Boarding Meeting for Year 2007
Board Lot as of 31 January 2008
Incorporation of Hemotek Renal Center
Statement of Changes on Beneficial Ownership of Securities
Statement of Changes on Beneficial Ownership
Board Lot as of 29 February 2008
Postponement_of_2008_Annual_Shareholders_Meeting
Modification_on_the_Incorporation_of_Hemotek_Renal_Center
New_Website_and_Email_Address
Directors Attendance in Corporate Governance Seminar
Approval and Authorization for Issuance of 2007 Audited Financial Statements
Board_Approval of Reappointment of Nomination Committee Member and Nominees for Directors 2008
Euro-Med 17A for the year ended 31 December 2007
Computation of Public Ownership as of 31March2008
Board Lot as of 31 May 2008
Euro-Med 2008 General Information Sheet
Euro-Med Preliminary Information Statement Notice of Annual Shareholders Meeting 18June2008 Management Report and Financial Statement
Euro Annual Shareholders Meeting 18June2008
Euro Organizational Meeting 18 June2008
General Information Sheet for year 2008
List of Shareholders of Record 19 May 2008
New Foreign Ownership Level
SEC 17Q First Quarter 2008
SEC Approval of the Amendment of By-Laws
Approval of the Application for Confirmation as an Exempt Transaction
BOI Approval for P1.3B Euro-Med Expansion
Board Lot as of 30 June 2008
Board Lot as of 30 September 2008
Board Lot as of 31 July 2008
Euro Public Ownership Report as of 30June2008
News Article 8% Profit Growth
News Article on BOI Approval on Euro-Med Project
PSE Approval on 10% Stock Dividend
Quarterly Report for the period 30 June 2008
Top 100 Stockholders as of 30 June 2008
Statement of Changes in Beneficial Ownership July 2008
2007 Corporate Governance Scorecard
Board Lot as of 31 October 2008
Euro Public Ownership Report as of 30 September 2008
2008 Corporate Governance Scorecard
Board Lot as of 30 November 2008
BOD Declaration of 10% Stock Dividend 17 Dec 2008
Dividend Policy
Euro-Med 17Q for quarterly ended 30 September 2008
Promotions and New Appointment of Officers 17 Dec 2008
Reply to unusual price movement 18 December 2008
Public Ownership as of 31 December 2008
Euro Top 100 Stockholders as of 31 Dec 2008
Certification of Directors Attendance and Compliance of Manual on Corporate Governance for year 2008
Board Lot as of 31 Dec 2008
Board Lot as of 31 January 2009
Amended Certification on Manual of Corporate Governance for year 2008
2008 Annual Report
Annual Meeting of Shareholders and Approval on Issuance of 2008 Audited Financial Statements
Board Lot as of 28 February 2009
Board Lot as of 31 March 2009
Nominations Committee Appointment Guidelines and Nominees
Ratification of Collective Bargaining Agreement 13 Mar 2009
Reappointment of the Audit Commitee for the year 2009-2010
Top 100 Stockholders as of 31 March 2009
17Q as of 31 March 2009
2009 Definitive Information Statement
2009 Preliminary Information Statement
Amended Board Lot as of 30 April 2009
Board Lot as of 30 April 2009
Certification of Independent Director
Public Ownership as of 31 March 2009
Stockholders List as of Record Date: 18 May, 2009
2009 Annual Shareholders Meeting
2009 Organizational Meeting of Board of Directors
20090528 Update of Corporate Information
20090531 Board Lot
20090630 Board Lot
20090630 Computation of Public Ownership
20090630 Top 100 Stockholders
20090714 Licensed Transfer Agent
20090804 Statement of Changes in Beneficial Ownership 23-B
Form 23-B
Euro-Med 17 Q Second Quarter
Board Lot
Resignation of Officer
Resignation and Appointment of Officer
Board Lot as of 30 September 2009
Top 100 Stockholders as of 30 September 2009
17-Q for the period ending 30 September 2009
2009 Corporate Governance Scorecard
Appointment of Officer 21 October 2009
Board Lot as of 31 October 2009
Changes in Shareholdings 11 November 2009
Changes in Shareholdings 13 October 2009
Computation of Public Ownership as of 30 September 2009
Initial Statement of Beneficial Ownership 22 October 2009
2009 Certification of Board Attendance and Manual of Corp. Governance
2010 Jan 20 Increase of Capital Stock and Paid-Up Capital of Hemotek Renal Center Inc. Euro-Med's Subsidiary
Board Lot as of 30 November 2009
Board Lot as of 31 December 2009
Board Lot as of 31 January 2010
Public Ownership as of 31 December 2009
Top 100 Stockholders as of 31 December 2009
2010 Annual Shareholders Meeting Board of Directors Nominees & Issuance of 2009 Audited Financial Statements
Annual Report 17-A for the year ended 31 December 2009
Appointment of Audit and Nominations Committee for year 2010-2011 & Appointment of Officer
Board Lot as of 28 February 2010
Board Lot as of 31 March 2010
Initial Statement of Beneficial Ownership Danilo Lorico
Top 100 Stockholders as of 31 March 2010
Computation of Public Ownership as of 31 March 2010
17Q for the period ending 31 March, 2010
Declaration of 8.46710895% Stock Dividend May 12, 2010
Various Disclosures May 12, 2010
Board Lot as of 30 April 2010
Direct and Indirect Ownership of Issuers Directors Principal Officers and Principal Stockholders
Initial Statement of Beneficial Ownership Edwin D Feist
17Q_for_the_period_30_June_2010
2010_Amended_Manual_on_Corporate_Governance
2010_Certification_of_Independent_Directors
2010_Directors_Attendance_on_Corporate_Govenance_Seminar
2010_Preliminary _Information_Statement_(Final)
20100709_Certification_Implementation_of_the_Amended_Rule_on_Lodgment_of_Securities
20100728_Sworn_Certificate
20100818_New_Subsidiary
20100819_Application_to_SEC_Increase_of_Authorized_Capital_Stock
Board_Lot_as_of_30_June_2010
Board_Lot_as_of_31_July_2010
Board_Lot_as_of_31_May_2010
Euro-Med_Masterlist_as_of_21_June_2010
Public_Ownership_as_of_30_June_2010
Results_of_2010_Annual_Shareholders_Meeting
Results_of_2010_Organizational_Meeting
SEC_Approval_on_Increase_of_Capital_Stock_of_the_Corporation's_Wholly_Owned_Subsidiary
Top_100_Stockholders_as_of_30_June_2010
20100922 SEC Approval on Euro-Med's Increase in Capital Stock
20100923 Proposed Record Date and Distribution Date of Stock Dividend
20100929 SEC Approval on Record Date and Payment Date
20101012 Euro Med Acquisition of GSK Derma Products
20101015 Statement of Changes in Beneficial_Ownership Evergreen Stock Brokerage
Board Lot 30 September 2010
Board Lot as of 31 August 2010
Computation on Public Ownership as of 30 September 2010
Top 100 Stockholders and Beneficial Ownership as of 30 September 2010
11222010 Statement of Changes in Beneficial Ownership 23B
20110215 Updated CIO
20110221 Revised Manual on Corporate Governance
20110307 Evergreen Stock Brokerage Changes in Shareholdings
Board Lot as of 28 February 2011
Board Lot as of 30 November 2010
Board_Lot_as_of_31_December_2010
Board_Lot_as_of_31_January_2011
Board_Lot_as_of_31_October_2010
Certification_on_Directors_Attendance_in_Board_Meetings_for_year_2010
Compliance_on_Manual_on_Corporate_Governance_for_year_2010
Computation_of_Public_Ownership_as_of_07_March_2011
January_04_2011_Completion_of_Transaction
PSE_Corporate_Governance_Survey_for_year_2010
Statement_of_Changes_in_Beneficial_Ownership_of_Evergreen_07_March_2011
Top_100_Stockholders_and_Beneficial_Ownership_as_of_31_December_2010
2010_Annual_Report
2011_Annual_Shareholders_Meeting_Nominees_for_Election_as_BOD_Approval_and_Authorization_of_FS_Issuance_Declaration_of_7_percent_Stock_Dividend
2011_Certification_of_Independent_Directors
2011_Preliminary_Information_Statement
20110328_Completion_of_Acquisition
Appointment_of_Audit_and_Nomination_Committee_Members_for_year_2011-2012
Board_Lot_as_of_30_April_2011
Board_Lot_as_of_31_March_2011
Public_Ownership_as_of_31_March_2011.pdf
Top_100_Stockholders_as_of_31_March_2011
Euro-Med General Information Sheet 2011
Results of Stockholders and Organizational Meeting June 15, 2011
Board Lot as of 30 June 2011
Board Lot as of 31 May 2011
Public Ownership EURO June 30 2011
Quarterly Report ending 31 March 2011
Top 100 Stockholders and Beneficial Ownership as of 30 June 2011
17Q for the period ending 30 June 2011
19 July 2011 Increase of Capital Stock and Paid-Up Capital and Increase in Number of Directors of a Subsidiary
Board Lot as of 31 August 2011
Board Lot as of 31 July 2011
 
 
EURO-MED Disclosures submitted to SEC
Euro-Med 17A for the year ended Decmber 31 2006
Fire Incident at Euro-Med's Office
2007 Organizational Meeting of Board of Directors, 20 June 2007
Amended Disclosure: List of Elected Officers 2007-2008
Resignation and Appointment of Corporate Secretary
Euro-Med's Manila Office Return to PPL Building
2007 Corporate Governance Scoreboard for Publily-listed Company
Declaration 10% Stock Dividend by the Board of Directors
Amendment of Manual on Corporate Governance
Certification on Corporation's Compliance with its Manual on Corporate Governance for year 2007
Certification on the Attendance of Directors in the Board Meetings for the year 2007
Incorporation of Hemotek Renal Center
Statement of Changes on Beneficial Ownership of Securities
Statement of Changes on Beneficial Ownership
Euro 17Q 3rd Quarter
Modification_on_the_Incorporation_of_Hemotek_Renal_Center
Postponement_of_2008_Annual_Shareholders_Meeting
New_Website_and_Email_Address
Directors Attendance in Corporate Governance Seminar
Approval and Authorization for Issuance of 2007 Audited Financial Statements
Board Approval of Reappointment of Nomination Committee Members and Nominees for Directors 2008
Euro-Med 17A for the year ended 31 December 2007
Euro Stockholders and Organizational Meeting 18 June2008
General Information Sheet for year 2008
SEC 17Q First Quarter 2008
BOI Approval for P1.3B Euro-Med Expansion
News Article on BOI Approval on Euro-Med Project
Quarterly Report for the Period Ended 30 June 2008
Statement of Changes in Beneficial Ownership July 2008
2007 Corporate Governance Scorecard
Euro-Med Preliminary Information Statement Notice of Annual Shareholders Meeting 18 June 2008 Management Report and Financial Statement
2008 Corporate Governance Scorecard
BOD Declaration of 10% Stock Dividend 17 Dec 2008
Euro-Med 17Q for quarterly ended 30 September 2008
Form 23-A Angelica Garcia
Form 23-A Dinah Trivilegio
Form 23-A Enrique Raymond Yap
Form 23-A Isleen Sy
Form 23-A Leonida Martin
Form 23-A Marie Joy Tapawan
Form 23-A Michael Vincent Yap
Form 23-B Arnold Ong
Form 23-B Enrique Yap
Form23-B Johnny Yap
Promotions and New Appointment of Officers 17 Dec 2008
Amended Certification on Manual of Corporate Governance for year 2008
Certification on Compliance of Manual of Corporate Governance for year 2008
Certification on Directors Attendance for year 2008
Annual Meeting of Shareholders and Approval on Issuance of 2008 Audited Financial Statements
Nominations Committee Appointment Guidelines and Nominees
Ratification of Collective Bargaining Agreement 13 Mar 2009
Reappointment of Audit Committee for year 2009-2010
2008 Annual Report
17Q as of 31 March 2009
Certification of Independent Director
2009 Annual Shareholders Meeting
2009 Euro-Med GIS.pdf
2009 Organizational Meeting of Board of Directors
20090804 Statement of Changes in Beneficial Ownership 23-B
Form 23-B
Euro-Med 17 Q Second Quarter
Resignation of Officer
Initial Statement of Beneficial Ownership
17-Q for the period ending 30 September 2009
2009 Corporate Governance Scorecard
Changes in Shareholdings 13 October 2009
Initial Statement of Beneficial Ownership 21 October 2009
Euro-Med Parent FS for the year ended 31 December 2009
Statement of Changes in Beneficial Ownership 11 November 2009
Statement of Changes in Beneficial Ownership 14 October 2009
2009 Certification of Board Attendance and Manual of Corporate Governance
Initial Statement of Beneficial Ownership Danny Lorico
Appointment of Audit & Nominations Committee for year 2010-2011 & Appointment of Officer
Annual Report 17-A for the year ended 31 December 2009
17Q for the period ending 31 March, 2010
2010_Amended_Manual_on_Corporate_Governance
2010_Certification_of_Independent_Directors
2010_Directors_Attendance_on_Corporate_Governance
2010_Euro-Med_GIS
20100818_New_Subsidiary
Results_of_2010_Annual_Shareholders_Meeting
Results_of_2010_Organizational_Meeting
17Q for the period ending 30 September 2010
20110221_Revised_Manual_on_Corporate_Governance
January_24_2011_Completion_of_Transaction
20110307_Evergreen_Stock_Brokerage_Changes_in_Shareholdings
Computation_of_Public_Ownership_as_of_07_March_2011
2011 Preliminary Information Statement
Euro-Med (Parent) FS with SEC & BIR Stamp for the year ended December 31, 2010
 
 
bg_nav